APL1, an altered peptide ligand derived from human heat-shock protein 60, increases the frequency of Tregs and its suppressive capacity against antigen responding effector CD4 + T cells from rheumatoid arthritis patients
| Image |  |
|---|---|
| Description | scientific article published on 30 May 2016 |
| Author/s |
author: Willem van Eden |
| Publication date | May 30, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |